廣告
香港股市 已收市
  • 恒指

    17,718.61
    +2.14 (+0.01%)
     
  • 國指

    6,331.86
    +7.81 (+0.12%)
     
  • 上證綜指

    2,967.40
    +21.55 (+0.73%)
     
  • 滬深300

    3,461.66
    +7.54 (+0.22%)
     
  • 美元

    7.8085
    -0.0003 (-0.00%)
     
  • 人民幣

    0.9295
    -0.0008 (-0.09%)
     
  • 道指

    39,164.06
    +36.26 (+0.09%)
     
  • 標普 500

    5,482.87
    +4.97 (+0.09%)
     
  • 納指

    17,858.68
    +53.53 (+0.30%)
     
  • 日圓

    0.0484
    +0.0001 (+0.14%)
     
  • 歐元

    8.3617
    +0.0039 (+0.05%)
     
  • 英鎊

    9.8770
    +0.0080 (+0.08%)
     
  • 紐約期油

    82.36
    +0.62 (+0.76%)
     
  • 金價

    2,347.00
    +10.40 (+0.45%)
     
  • Bitcoin

    61,409.63
    +328.74 (+0.54%)
     
  • CMC Crypto 200

    1,281.55
    -2.28 (-0.18%)
     

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why This 1 Growth Stock Should Be On Your Watchlist

Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

廣告

HealthEquity (HQY)

Draper, UT-headquartered HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States.

HQY sits at a Zacks Rank #2 (Buy), holds a Growth Style Score of B, and has a VGM Score of B. Earnings and sales are forecasted to increase 32.4% and 16.5% year-over-year, respectively.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.07 to $2.98 per share. HQY boasts an average earnings surprise of 17.2%.

On a historic basis, HealthEquity has generated cash flow growth of 30.3%, and is expected to report cash flow expansion of 27.9% this year.

Investors should take the time to consider HQY for their portfolios due to its solid Zacks Rank rating, notable growth metrics, and impressive Growth and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HealthEquity, Inc. (HQY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research